MPM Capital Limited Partnership firm targets biotechnology, specialty pharmaceutical, and medical technology companies. With more than $2 billion of committed capital in four funds, it invests in all stages of a firm's development, typically offering between $5 million and $50 million per transaction, and takes a long-term approach. MPM Capital's portfolio includes about 60 firms, including Affymax, AVEO Pharmaceuticals, Oxagen, and Surface Logix. Most of MPM Capital's investments are in US concerns, but the company also seeks opportunities in Europe, and more recently, Asia and Australia.

Founded in 1889, Bank of Bermuda was bought by British banking giant HSBC in 2004. The Bank of Bermuda Limited provides fund administration, trust, custody, asset management, and banking services globally. The bank operates through four divisions: Global Fund Services, Private Client Services, Corporate Banking, and Community Banking. The Global Fund Services division provides fund administration products, banking, and global custody services, including hedge funds, emerging market funds, funds of funds, and private equity funds to investment industry. The Private Client Services division provides private trust and investment services to high net worth individuals and families. The Corporate Banking division provides cash management services to offshore insurance management companies, multinational corporations, and local Bermuda-based companies.

Norwest Venture Partners (NVP) invests mainly in information technology companies focused on the semiconductor, software, and consumer Internet sectors. It typically invests between $10 million to $15 million in start-up or early-stage firms and assists its portfolio companies with executive recruiting, forming strategic alliances, and financial and legal matters. An affiliate of Wells Fargo, NVP closed its 11th fund worth some $1.2 million in late 2009. It is the firm's largest fund to date. NVP has more than $3.7 billion of capital under management and has invested in more than 450 companies.

Tudor Ventures is the venture capital and private equity arm of Tudor Investment Corporation, an internationally recognized, $10 billion in assets, diversified investment management firm. Tudor has been investing in venture capital and other private equity opportunities since the early 1990's. Over this time, Tudor and its principals have invested in over 75 companies, with a strong record of investment success, and currently manage over $700 million in capital commitments. Tudor Ventures announced the closing of our third fund, Tudor Ventures III L.P., in June 2007 with $262 million in capital commitments. Limited partners in this fund include large institutional, endowment, fund of funds, and high net-worth individual investors along with significant investments from Tudor's proprietary capital and the Tudor Ventures' principals.

Harbour Centre Development puts its money behind hotels and restaurants, real estate development, and other investment opportunities in Hong Kong and Singapore. Harbour company's crown jewel is The Marco Polo Hongkong Hotel (which the company owns and manages). Other investments include commercial property development near the hotel and residential property development in Hong Kong through subsidiaries Manniwoth Company and Kowloon Properties Company. Harbour Centre Development is a subsidiary of The Wharf (Holdings) Limited through a 66% stake.

Conning & Company was founded in 1912 and is headquartered in Hartford, Connecticut with additional offices in Dublin and London. Conning & Company was formerly a subsidiary of Swiss Reinsurance Co. Conning & Company provides insurance asset management and investment management services, and insurance-related research publications. It specializes in fixed-income products for institutional investors. The company, through its subsidiaries, offers insurance research, including information products, and insights and analyses of issues confronting the insurance industry, as well as provides insurance asset management, including portfolio management, and investment accounting and reporting services in the United States and Europe. It also provides access to various financial investment products, such as structured securities, derivative strategies and investment banking, and insurance and banking equity research.

BB BIOTECH AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB BIOTECH AG invests mainly in companies operating in such sectors as oncology, cardiovascular diseases, infectious diseases and autoimmune diseases. As of December 31, 2009, the Company’s portfolio comprised 23 companies, including Actelion, Gilead, Celgene, Genentech, Biogen Idec, Vertex Pharmaceuticals, Elan, Basilea Pharmaceuticals and Roche Holding GS, among others. The investments are held through its wholly owned subsidiaries, which include Biotech Focus NV, Biotech Invest NV, Biotech Target NV and Biotech Growth NV.

Crowell Weedon & Co. was founded in 1932 and is headquartered in Los Angeles, California with additional offices in Carlsbad, West Covina, Encino, Newport Beach, Pasadena, San Diego, La Jolla, and Long Beach, California. Crowell, Weedon & Co. (CWC) provides financial advisory and securities brokerage services. The firm’s services include financial planning, fee-based investment programs, customized retirement strategies, investment advisory, corporate finance, preferred and common stocks, and tax-deferred annuities and insurance.

Argosy Private Equity business, the investment firm focuses on buyouts, recapitalizations, and financing of middle-market firms in the eastern half of the US with annual sales between $15 million and $100 million. The company prefers to invest in smaller firms with room for growth, and it provides them not only with capital, but operational support and strategic planning. Typical investments range from $3 million to $9 million per transaction. Its portfolio contains stakes in some 35 companies, mainly in the manufacturing, industrial electronics, and industrial and business services sectors.

Grotech Management Company was founded in 1984 by managing general partner Frank Adams. Grotech Ventures invests in early, expansion, and growth stage technology companies. The company focuses on long-term investments in communications, information technology, software, and Internet businesses. Grotech's portfolio of about 30 companies includes telecommunications equipment provider Aztek Networks, voice-over-IP company BroadSoft, and broadcasting technology developer ibiquity Digital Radio. Investments range from $500,000 to $5 million.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.